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Abstract The optimum treatment of gastric varices has still to be defined. Lesser curve gastric varices may be treated by injection sclerotherapy, but this has a limited role in the treatment of fundal gastric varices. Surgical intervention is commonly needed but carries a high mortality in patients with advanced liver disease. This study evaluated the use of thrombin for the treatment of gastric varices in 11 consecutive patients (nine with fundal, two with high lesser curve varices), identified as having bled from this site. Bovine thrombin (1000 U/ml) was injected intravariceally (mean volume 5.5 ml, range 2-10 ml) producing initial haemostasis in all 11 Accepted for publication 14 December 1993 Ten (91%) of the patients had previously had sclerotherapy for oesophageal varices, and one (9%) had previously had ethanolamine oleate injected into a fundal gastric varix, which had been identified as the site of haemorrhage. At the time of presentation oesophageal varices were still present in eight (73%), being assessed as large in half of these patients (Table I) .
At the index bleed four (36%) patients were actively bleeding, three from fundal gastric varices and one from lesser curve gastric varices. Seven (63%) had spontaneously stopped bleeding (six had bled from fundal/greater curve varices and one from lesser curve varices). In one of the patients who was actively bleeding views of the fundus were obscured by an adherent blood clot, but it was clear that bleeding had originated from fundal varices at the subsequent endoscopy. No of injection episodes 20 5 15
Mean volume thrombin used (ml) 5-5
5
Range (ml)
2-10 4-10
2-10
Haemostasis for the presenting episode was achieved in all patients with a single session of thrombin injection. The patients had a total of 20 injection sessions with a median of two injections (range 1-3) per patient to achieve obliteration. The mean volume of thrombin injected was 5.5 ml (5500 U/ml) per session (Table II) .
REBLEEDING
Rebleeding during the same admission occurred in one patient from a friable gastrooesophageal junction distant from the treated gastric varix. Late rebleeding (follow up 6-13 months, median 9 months), occurred in two patients. One rebled from oesophageal varices and the other rebled from lesser curve gastric varices during the preterminal phase of severe alcoholic hepatitis (Table III) .
COMPLICATIONS
Apart from rebleeding no clinically significant major/minor complications attributable to bovine thrombin injection were recorded.
Discussion
The treatment of gastric varices remains controversial7 but our results suggest that thrombin is an effective treatment for the short and medium term control of bleeding from gastric varices.
Thrombin proved straightforward to inject in the acute setting, and requires few injection sessions (median 2; range 1-3) to achieve luminal obliteration. It is, however, acknowledged that only four of our patients could be identified as actively bleeding at the time of the initial endoscopy. One of these patients was not identified as having bled from fundal gastric varices at the initial endoscopy because of limited views of the fundus. This problem is well reported in patients bleeding from gastric varices,15 and represents an important limitation to accurate diagnosis and direction of treatment.
The safety of intravarix bovine thrombin has been suggested in other reports and in particular there is no evidence to support thrombosis distant from the site of injection. '3 One important advantage of this approach is the absence of any mucosal damage and ulceration after the injection that is characteristic of sclerosants'6 and tissue adhesives.9
This permitted the use of multiple injections to thrombose the varices. Although rebleeding resulting from mucosal damage is reported to be uncommon and easily controlled after the use of tissue adhesives9 the use of thrombin removes one of the important causes of rebleeding after previous endoscopic treatment. 17 The longterm efficacy of thrombin is unknown but our results show effective control of bleeding up to 13 months after the initial injection session without evidence, in those patients who had a subsequent endoscopy, of varix recurrence. Overall thrombin seems to be a safe and simple agent to use for controlling active gastric variceal bleeding as well as providing longer term protection against rebleeding. There would seem to be advantages for the use of thrombin compared with sclerosants as well as the tissue adhesives both of which produce mucosal damage. There is the additional problem of the toxicity of the tissue adhesives. 10 The ability, however, to attain adequate vision (particularly for fundal variceal bleeding) will remain a limitation for any endoscopic treatment. In such circumstances failure of the endoscopic approach should be recognised with recourse to surgery or perhaps transjugular intrahepatic portal systemic shunts. 18
The data presented in this paper have previously been presented, in abstract form, at the British Society of Gastroenterology (Gut 1993; 34 (suppl 1): S48). 
